Dr. Adam S. Arthur named Chief Clinical Strategy Officer of inTRAvent Medical

Dr. Adam S. Arthur has been named Chief Clinical Strategy Officer (CCSO) of inTRAvent Medical. In this role, Arthur will lead the clinical strategy for the launch of SOLOPASS, inTRAvent’s platform for external ventricular drain placement. He will also oversee the development of additional minimally invasive applications.

The SOLOPASS system combines 2-D and 3-D ultrasound imaging, artificial intelligence and trajectory guidance to provide real-time, intra-procedural localization and navigation in a critical care setting. The system is designed to overcome the limitations of traditional systems, which rely on preoperative images that can become unreliable and no longer reflect actual anatomy due to brain shift or evolving pathology.

This appointment reflects Semmes Murphey’s ongoing commitment to advancing the field of neuroscience through innovation- improving care today while helping shape the future of neurosurgery.

Read more about this announcement and Dr. Arthur’s role here.